Spain’s Hipra Eyes EU Use of COVID-19 Vaccine, Rivaling Novavax

AMER — Spain’s Hipra is confident there will be European Union demand for its experimental COVID-19 vaccine once approved for use as it is designed to protect against new variants, can be moved easily and produced in mass quantity, a top executive said. Read More